No Detail Found!

Assessment of interleukin-10 levels in Iraqi diabetic Type 2 patients infected with toxoplasmosis

Author(s)
Sarah Ali Saeed Department of Biology, College of Education for Pure Science (Ibn Al- Haitham), University of Baghdad, Baghdad - Iraq
Israa Kasim Al-Aubaidi Department of Biology, College of Education for Pure Science (Ibn Al- Haitham), University of Baghdad, Baghdad - Iraq
Abstract
Background: Toxoplasmosis is a disease caused by an obligate intracellular protozoan parasite Toxoplasma gondii that infects birds and mammals as an intermediate host while infecting cats as a definitive host. Diabetes mellitus is a global metabolic disorder that appeared due to inappropriate hyperglycemia. Interleukin-10 is an immunoregulatory cytokine that plays a main role in modulating inflammation, it’s considered as main inhibitory cytokine against the action of inflammatory cytokines such as IL-12. The main aim of this study is to assess the levels of IL-10 in Iraqi diabetic type 2 infected with toxoplasmosis. Methods: This study concluded 109 cases of Iraqi diabetic type 2 patients and 80 samples of healthy individuals collected from private lab in Baghdad, Iraq, during period from March to June 2022 with age mean 49.9 ± 1.29. Results: The results showed that the group of diabetes has the highest level of glucose in diabetes diagnostic tests 7.9 ± 0.178 HbA1C, 174.55 ± 3.96 mg/dl FBS and 216.89 ± 4.96 mg/dl RBS respectively. Moreover, 51/109 samples of diabetic patients have highest level of IgG anti-Toxoplasma 34.95 ± 7.5 UI/mL in CMIA followed by 30/80 samples of healthy individuals have seropositive for the same antibody 32.7 ± 8.45 UI/mL in the same assay with significant differences While, all samples were seronegative for IgM anti-Toxoplasma. The group of healthy control has the highest levels of IL-10 in ELISA 320.43 ± 17.64 pg/ml followed by the group of diabetic patients 138.38 ± 5.69 pg/ml. Also, the concentration of this interleukin was in the group of toxoplasmosis patients which considered as a control positive 115.45 ± 4.44 pg/ml. While, the group of diabetic patients with toxoplasmosis has the lowest concentration of the interleukin 102.3 ± 7.05 pg/ml with highly significant differences. Conclusion: The conclusion of this study is the IL-10 has been shown highest levels in healthy control in comparison with other study groups.
Publication Details
Page(s) 62-66
DOI DOI not available
Published Journal: Advancements in life sciences, Volume: 10, Issue: 1, Year: 2023

Request the full text from PASTIC

Keywords
IgG, IgM, toxoplasmosis, IL-10, DMT2
0

Citations

0

Downloads

74

Views